Table 3.
SWE in Patients with NAFLD
| Study | n | Age | Mean BMI kg/m(2) | Patients with Advanced Fibrosis (%) | AUROC for Advanced Fibrosis (F3-4) | Optimal Cut-off for F3-F4 (kPa) | Sensitivity (%) |
Specificity (%) |
System |
|---|---|---|---|---|---|---|---|---|---|
| Cassinotto102 | 291 | 56.7 | 32.1 | 43.3 | 0.89 | 8.3 | 91 | 71 | Aixplorer, Supersonic Imagine |
| Furlan92 | 57 | 50 | 34.8 | 42.1 | 0.89 | 8.1 | 71.4 | 94.4 | GE Healthcare Logiq E9 |
| Petzold104 | 33 | 53.3 | 30 | 27.3 | 1.00 | 8.94 | 100 | 100 | GE Healthcare Logiq E9 |
| Takeuchi105 | 71 | 50.8 | 29.2 | 45.1 | 0.82 | 13.07 | 63 | 57 | Aixplorer, Supersonic Imagine |
| Herrmann103 | 156 | 53.7 | 31.2 | 32.1 | 0.93 | 9.2 | 93.1 | 80.9 | Aixplorer, Supersonic Imagine |